Major Role for Hypoxia Inducible Factor-1 and the Endothelin System in Promoting Myocardial Infarction and Hypertension in an Animal Model of Obstructive Sleep Apnea

Journal of the American College of Cardiology

Volumn 53, Issue 15, 2009, Pages 1309-1317

  Belaidi, Elise ^a   Joyeux Faure, Marie ^a,b   Ribuot, Christophe ^a,b   Launois, Sandrine H ^a,b,c   Levy, Patrick ^a,b,c   Godin Ribuot, Diane ^a,b  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c HÔPITAL MICHALLON   (France)

Author keywords

endothelin; gene expression; hypoxia inducible factor 1; myocardial infarction; obstructive sleep apnea

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CHROMATIN IMMUNOPRECIPITATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HYPERTENSION; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; RISK FACTOR; SLEEP APNEA SYNDROME; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; ANOXIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; GENETIC PREDISPOSITION TO DISEASE; HEART; HYPERTENSION; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MYOCARDIAL INFARCTION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SLEEP APNEA, OBSTRUCTIVE; SULFONAMIDES;

EID: 63549129273     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.050     Document Type: Article

References (58)

1. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
2. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
3. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health study. Am J Respir Crit Care Med 173 (2006) 910-916
4. Arzt M., Young T., Finn L., Skatrud J.B., and Bradley T.D. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172 (2005) 1447-1451
5. Peker Y., Kraiczi H., Hedner J., Loth S., Johansson A., and Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 14 (1999) 179-184
6. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
7. Baguet J.P., Hammer L., Levy P., et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 23 (2005) 521-527
8. Alchanatis M., Tourkohoriti G., Kosmas E.N., et al. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 20 (2002) 1239-1245
9. Baguet J.P., Hammer L., Levy P., et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128 (2005) 3407-3412
10. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7 (2003) 35-51
11. Barcelo A., Barbe F., de la Pena M., et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27 (2006) 756-760
12. McNicholas W.T., and Bonsigore M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29 (2007) 156-178
13. Fletcher E.C., Lesske J., Qian W., Miller III C.C., and Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19 (1992) 555-561
14. Savransky V., Nanayakkara A., Li J., et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175 (2007) 1290-1297
15. Dematteis M., Julien C., Guillermet C., et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 177 (2008) 227-235
16. Joyeux-Faure M., Stanke-Labesque F., Lefebvre B., et al. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 98 (2005) 1691-1696
17. Park A.M., Nagase H., Kumar S.V., and Suzuki Y.J. Effects of intermittent hypoxia on the heart. Antioxid Redox Signal 9 (2007) 723-729
18. Kanagy N.L., Walker B.R., and Nelin L.D. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37 (2001) 511-515
19. Troncoso Brindeiro C.M., da Silva A.Q., Allahdadi K.J., Youngblood V., and Kanagy N.L. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293 (2007) H2971-H2976
20. Yamashita K., Discher D.J., Hu J., Bishopric N.H., and Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J Biol Chem 276 (2001) 12645-12653
21. Luft F.C. Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 11 (2002) 59-66
22. Lerman A., Holmes Jr. D.R., Bell M.R., Garratt K.N., Nishimura R.A., and Burnett Jr. J.C. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92 (1995) 2426-2431
23. Phillips B.G., Narkiewicz K., Pesek C.A., Haynes W.G., Dyken M.E., and Somers V.K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17 (1999) 61-66
24. Jordan W., Reinbacher A., Cohrs S., et al. Obstructive sleep apnea: plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides 26 (2005) 1654-1660
25. Gjorup P.H., Sadauskiene L., Wessels J., Nyvad O., Strunge B., and Pedersen E.B. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 20 (2007) 44-52
26. Allahdadi K.J., Walker B.R., and Kanagy N.L. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45 (2005) 705-709
27. Lefebvre B., Godin-Ribuot D., Joyeux-Faure M., et al. Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir Physiol Neurobiol 150 (2006) 278-286
28. Suzuki H., Swei A., Zweifach B.W., and Schmid-Schonbein G.W. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 25 (1995) 1083-1089
29. Schiffrin E.L. State-of-the-art lecture. Role of endothelin-1 in hypertension. Hypertension 34 (1999) 876-881
30. Belaidi E., Beguin P.C., Levy P., Ribuot C., and Godin-Ribuot D. Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat. Am J Physiol Heart Circ Physiol 294 (2008) H901-H908
31. Kraiczi H., Magga J., Sun X.Y., Ruskoaho H., Zhao X., and Hedner J. Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. J Appl Physiol 87 (1999) 2025-2031
32. Phillips S.A., Olson E.B., Morgan B.J., and Lombard J.H. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286 (2004) H388-H393
33. Greenberg H.E., Sica A., Batson D., and Scharf S.M. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 86 (1999) 298-305
34. Lariviere R., Sventek P., and Schiffrin E.L. Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats. Life Sci 56 (1995) 1889-1896
35. Li J.S., and Schiffrin E.L. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 25 (1995) 495-500
36. Gan X.T., Chakrabarti S., and Karmazyn M. Increased endothelin-1 and endothelin receptor expression in myocytes of ischemic and reperfused rat hearts and ventricular myocytes exposed to ischemic conditions and its inhibition by nitric oxide generation. Can J Physiol Pharmacol 81 (2003) 105-113
37. Kourembanas S., Marsden P.A., McQuillan L.P., and Faller D.V. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 88 (1991) 1054-1057
38. Hu J., Discher D.J., Bishopric N.H., and Webster K.A. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 245 (1998) 894-899
39. Minchenko A., and Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 208 (2000) 53-62
40. 2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280 (2005) 4321-4328
41. Peng Y.J., Yuan G., Ramakrishnan D., et al. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577 (2006) 705-716
42. Di Giulio C., Bianchi G., Cacchio M., et al. Oxygen and life span: chronic hypoxia as a model for studying HIF-1alpha, VEGF and NOS during aging. Respir Physiol Neurobiol 147 (2005) 31-38
43. Semenza G.L., and Prabhakar N.R. HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 9 (2007) 1391-1396
44. Kietzmann T., and Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16 (2005) 474-486
45. Zalba G., Beaumont F.J., Jose G.S., et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35 (2000) 1055-1061
46. Nanduri J., Yuan G., Kumar G.K., Semenza G.L., and Prabhakar N.R. Transcriptional responses to intermittent hypoxia. Respir Physiol Neurobiol 164 (2008) 277-281
47. Natarajan R., Salloum F.N., Fisher B.J., Kukreja R.C., and Fowler III A.A. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 98 (2006) 133-140
48. Hocher B., Rohmeiss P., Zart R., et al. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Cardiovasc Res 31 (1996) 499-510
49. Allahdadi K.J., Cherng T.W., Pai H., et al. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol 295 (2008) H434-H440
50. Chen Y.F., and Oparil S. Endothelin and pulmonary hypertension. J Cardiovasc Pharmacol 35 (2000) S49-S53
51. Chen J., He L., Dinger B., Stensaas L., and Fidone S. Role of endothelin and endothelin A-type receptor in adaptation of the carotid body to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 282 (2002) L1314-L1323
52. Patel N., Gonsalves C.S., Malik P., and Kalra V.K. Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1 alpha. Blood 112 (2008) 856-865
53. Nilsson D., Wackenfors A., Gustafsson L., et al. PKC and MAPK signalling pathways regulate vascular endothelin receptor expression. Eur J Pharmacol 580 (2008) 190-200
54. Torres M., and Forman H.J. Redox signaling and the MAP kinase pathways. BioFactors 17 (2003) 287-296
55. Bouallegue A., Bou Daou G., and Srivastava A.K. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 5 (2007) 45-52
56. Pernow J., and Wang Q.-D. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 33 (1997) 518-526
57. McNicholas W.T. Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome. Am J Physiol Regul Integr Comp Physiol 293 (2007) R1666-R1670
58. McArdle N., Devereux G., Heidarnejad H., Engleman H.M., Mackay T.W., and Douglas N.J. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159 (1999) 1108-1114